Marsh Supermarkets closing all in-store pharmacies
The struggling grocery chain told employees Friday morning that it plans to discontinue pharmacy operations and has sold customer prescription files to a national drug store chain.
Health Care & Life Sciences
Articles
UPDATE: Anthem loses appeal to overturn U.S. block of Cigna takeover
The decision is a likely final blow to Indianapolis-based Anthem’s bid to complete the $48 billion merger, which a lower-court judge had said should be stopped because it risked undermining competition in health-insurance markets.
IU Health, HealthNet to pay $18M to settle false-claims case
The lawsuit claimed the two health care providers left their pregnant patients’ care to lower-cost nurse midwives instead of having them treated by doctors. When billing Medicaid, the two claimed the services were provided by doctors, the complaint said.
Mainscape founder secretly assisted feds with American Senior Communities probe
The fact that Dave Mazanowski, whose firm provided landscaping services to the nursing home chain's properties, had been cooperating with investigators was revealed publicly for the first time in a recent court filing.
VA limiting new hiring as it aims to widen private care
The Department of Veterans Affairs is leaving thousands of positions unfilled, citing the need for a leaner VA as it develops a longer-term plan to allow more veterans to seek medical care in the private sector.
Speedway to ban smoking in grandstands starting in October
Beginning with the Red Bull Air Race, most of the smoke spectators see and smell from the Indianapolis Motor Speedway grandstands will waft from exhaust pipes or screeching tires.
Express Scripts rebounds as Anthem holds out hope of reconciliation
Express Scripts Holding Co. shares rose Wednesday after health insurer Anthem Inc., its biggest client, said it hasn’t ruled out using the pharmacy benefit manager after their contract expires.
Anthem’s quarterly profit zooms to $1B, handily beating analysts’ expectations
The Indianapolis-based health insurer, which operates Blue Cross Blue Shield plans in more than a dozen states, said earnings increased 44 percent in the first quarter and revenue climbed 11 percent, reaching $22.5 billion.
Lilly diabetes drug Jardiance falls short of quarterly sales predictions
Shares in Eli Lilly and Co. stock fell more than 3 percent Tuesday after the Indianapolis-based drugmaker released a quarterly earnings report that showed sales of potential blockbuster drug Jardiance missed expectations by a wide margin.
Lilly profit climbs 18 percent after one-time expenses
The Indianapolis-based drugmaker beat Wall Street expectations by 2 cents a share—performance it attributed to brisk sales of new products.
Express Scripts expects to be dumped by Anthem after 2019
The prescription drug manager said Indianapolis-based Anthem Inc., its biggest customer, doesn’t plan to extend its contract when it expires even though Express Scripts is offering major discounts.
IU, Regenstrief, Eskenazi team up to demystify electronic health records for med students
Physicians use electronic health records all day long. How will medical students learn about them? The AMA is rolling out a new program developed in Indianapolis.
Community makes latest push into oncology with $60M cancer center
Community Health Network’s new Cancer Center North, which will have its grand opening Saturday is designed to lift patients’ spirits as much as kill cancer cells.
How Dow won fight to save key product
When Dow AgroSciences needed to battle a proposed federal ban on one of its most important products, it drafted an army—its farmers.
Obamacare’s insurers struggle for stability amid Trump threats
Obamacare is stuck in limbo, and insurers and state regulators are struggling to set their plans for what’s increasingly shaping up as a chaotic year for the health-care program.
Lilly uses ‘horny goat weed’ to fend off Cialis royalty demands
Eli Lilly and Co. told a federal jury that a German company is trying to take credit for centuries-old Chinese medicine in seeking royalties on the use of its erectile-dysfunction drug Cialis to treat an enlarged prostate.
Lilly’s rheumatoid arthritis pill rejected by regulators
The drug, which has the proposed brand name Olumiant and is approved for use in Europe, was expected to be a big seller.
Fixes for ‘Obamacare’ markets not enough to impress insurers
The White House remained mum on the biggest concern. Insurers, doctors, hospitals and the business community have asked President Trump to preserve cost-sharing subsidies that pare down high deductibles and copayments for consumers with modest incomes.
Blame game over drug prices escalates with new ad campaign
Broadening its efforts to defuse outrage over skyrocketing prices, the pharmaceutical industry’s lobbying association has started an advertising campaign urging insurers to share with customers more of the benefits of rebates they’ve negotiated.
Indiana needle exchange bill heads to governor, who backs it
The state Senate approved the measure Thursday by a 32-16 vote after lengthy discussion about needle exchanges, which aim to reduce the spread of infectious diseases by providing people with clean syringes and discouraging needle sharing